Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Scheid

Showing results (61-70 of 200) with videos related to

Pageof 20
Sort By:
Ejhaem|May 18, 2026
European Recommendations for Transitioning the Care of Patients With Multiple Myeloma Treated With B-Cell Maturation Antigen Bispecific Antibodies From Academic Hospitals to Community-Based Centers and for Outpatient Step-Up DosingMaría-Victoria Mateos, Elena Zamagni, Massimo Gentile, et al.
Oncology Research and Treatment|August 28, 2025
Palliative Care for the Management of Patients with Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-Sectional Survey in Comprehensive Cancer CentersAnne Pralong, Marco Herling, Udo Holtick, et al.
Medical Microbiology and Immunology|July 14, 2017
Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantationRamona Gilles, Marco Herling, Udo Holtick, et al.
Transfusion|January 31, 2006
A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myelomaIngmar Bruns, Ulrich Steidl, Ralf Kronenwett, et al.
Annals of Hematology|February 7, 2025
A cross-sectional survey on health care professionals' approaches, challenges, and support needs when addressing life threat with recipients of an allogeneic hematopoietic stem cell transplantation and with their relativesAnne Pralong, Steffen T Simon, Udo Holtick, et al.
Annals of Hematology|August 15, 2014
CD4+ T cell counts reflect the immunosuppressive state of CD4 helper cells in patients after allogeneic stem cell transplantationUdo Holtick, Lukas P Frenzel, Alexander Shimabukuro-Vornhagen, et al.
Critical Reviews in Oncology/Hematology|April 9, 2013
Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis-A systematic review and meta-analysisSebastian Theurich, Hans Fischmann, Geothy Chakupurakal, et al.
Bone Marrow Transplantation|March 3, 2023
CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortalityKirsten Alexandra Eberhardt, Verena Jung, Elena Knops, et al.
The British Journal of Ophthalmology|June 9, 2016
Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort studyVolkan Tahmaz, Uta Gehlsen, Laura Sauerbier, et al.
British Journal of Haematology|July 7, 2026
Real-world prevalence and prognostic significance of hepatotoxicity after chimeric antigen receptor T-cell therapyJulius Hollnberger, Tim Richardson, Philipp Gödel, et al.
Pageof 20

Showing results (61-70 of 200) with videos related to

Sort By:
Pageof 20
Ejhaem|May 18, 2026
European Recommendations for Transitioning the Care of Patients With Multiple Myeloma Treated With B-Cell Maturation Antigen Bispecific Antibodies From Academic Hospitals to Community-Based Centers and for Outpatient Step-Up DosingMaría-Victoria Mateos, Elena Zamagni, Massimo Gentile, et al.
Oncology Research and Treatment|August 28, 2025
Palliative Care for the Management of Patients with Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-Sectional Survey in Comprehensive Cancer CentersAnne Pralong, Marco Herling, Udo Holtick, et al.
Medical Microbiology and Immunology|July 14, 2017
Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantationRamona Gilles, Marco Herling, Udo Holtick, et al.
Transfusion|January 31, 2006
A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myelomaIngmar Bruns, Ulrich Steidl, Ralf Kronenwett, et al.
Annals of Hematology|February 7, 2025
A cross-sectional survey on health care professionals' approaches, challenges, and support needs when addressing life threat with recipients of an allogeneic hematopoietic stem cell transplantation and with their relativesAnne Pralong, Steffen T Simon, Udo Holtick, et al.
Annals of Hematology|August 15, 2014
CD4+ T cell counts reflect the immunosuppressive state of CD4 helper cells in patients after allogeneic stem cell transplantationUdo Holtick, Lukas P Frenzel, Alexander Shimabukuro-Vornhagen, et al.
Critical Reviews in Oncology/Hematology|April 9, 2013
Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis-A systematic review and meta-analysisSebastian Theurich, Hans Fischmann, Geothy Chakupurakal, et al.
Bone Marrow Transplantation|March 3, 2023
CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortalityKirsten Alexandra Eberhardt, Verena Jung, Elena Knops, et al.
The British Journal of Ophthalmology|June 9, 2016
Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort studyVolkan Tahmaz, Uta Gehlsen, Laura Sauerbier, et al.
British Journal of Haematology|July 7, 2026
Real-world prevalence and prognostic significance of hepatotoxicity after chimeric antigen receptor T-cell therapyJulius Hollnberger, Tim Richardson, Philipp Gödel, et al.
Pageof 20